
Results
2
2 companies
Starpharma Holdings
Market Cap: AU$315.9m
A biopharmaceutical company, engages in the research, development and commercialization of dendrimer technology for pharmaceutical, healthcare applications, life science, and other applications in Australia and internationally.
SPL
AU$0.75
7D
8.7%
1Y
681.3%
Neuren Pharmaceuticals
Market Cap: AU$2.3b
A biopharmaceutical company, develops drugs for the treatment of neurological disorders.
NEU
AU$18.00
7D
9.4%
1Y
6.3%